27 citations
,
March 2018 in “Fertility and Sterility” This study found that in Chinese women with PCOS, pretreatment with ethinylestradiol/cyproterone acetate was associated with a lower risk of gestational diabetes, pregnancy-induced hypertension, and premature delivery compared to those without pretreatment.
Higher pre-pregnancy BMI is linked to more stress in mothers and more behavioral problems in two-year-old children.
June 2003 in “Obstetrical & Gynecological Survey” In this study, the size of vaginal prolapse was significantly linked to preoperative vaginal length and the length of vaginal excision following the Michigan four-wall sacrospinous suspension.
1 citations
,
July 2010 in “PubMed” July 2012 in “Reactions Weekly” Crushed finasteride tablets can harm pregnant and fertile women.
88 citations
,
January 2011 in “Annals of Dermatology” This review discusses the reclassification of pregnancy-related skin diseases and provides a management algorithm but reports no new clinical findings.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride is risky during pregnancy, but the chance of harm from a male partner taking it is low if handled safely.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Pregnant women should avoid handling crushed finasteride tablets, but exposure through a male partner's semen is minimal.
74 citations
,
February 2018 in “Stroke” This review discusses unique stroke risk factors in women, such as hormonal and reproductive influences, and highlights the need for further research to better predict and manage these risks.
February 2026 in “Journal of the American Academy of Dermatology” Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.
January 2019 in “Obstetrics & Gynecology International Journal” This study found that acne prevalence varies among ethnic groups and is often linked to gynecological disorders in women, with hormonal changes as a common factor.
4 citations
,
February 2011 in “Nature Reviews Endocrinology” Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.
4 citations
,
March 2002 in “Journal of the American Pharmaceutical Association” This review discusses various skin conditions affecting women throughout their lives and highlights the pharmacist's role in advising on management and treatment, but it reports no new clinical results.
March 2007 in “Journal of Obstetrics and Gynaecology Canada” This review discusses the diagnosis and treatment of hyperandrogenism in women, emphasizing that cyproterone acetate is effective for severe hirsutism, though it reports no new clinical findings.
5 citations
,
June 2017 in “BJU international” In this review, the authors highlight the occupational risks faced by pregnant urologists, such as radiation and exposure to certain medications, and emphasize the importance of avoiding specific drugs and practicing good hygiene, but note limited data on radiation risk.
87 citations
,
July 2012 in “Expert Review of Clinical Immunology” This review outlines pregnancy risks in systemic lupus erythematosus and emphasizes that active lupus nephritis at conception increases the risk of flares and poor obstetric outcomes; it reports no new clinical findings.
October 2023 in “International Journal For Multidisciplinary Research” This review discusses the increased health risks associated with polycystic ovary syndrome and highlights the effectiveness of exercise, a healthy diet, and weight management in reversing obesity-related reproductive issues.
This article reviews the characteristics and risks associated with polycystic ovary syndrome, such as insulin resistance and obesity, highlighting a need for further understanding of its pathogenesis; it reports no new findings.
49 citations
,
March 2009 in “Archives of Gynecology and Obstetrics” This study found that age, pre-pregnancy BMI, and family history of diabetes were independent predictors of gestational diabetes in Iranian women, with selective screening missing few cases among low-risk groups.
September 2025 in “JAAD reviews.” In this systematic review and meta-analysis, researchers evaluated the link between alopecia areata and adverse pregnancy outcomes, motivated by the condition's association with other autoimmune diseases that increase pregnancy risks. Results are not provided in the abstract.
November 2024 in “Rheumatology Advances in Practice” In this case report, the use of ocrelizumab in the second trimester of a high-risk pregnancy with active juvenile-onset systemic lupus erythematosus resulted in a successful birth without complications, although its safety in pregnancy remains unlicensed and further evaluation is needed.
24 citations
,
March 2015 in “Best Practice & Research in Clinical Obstetrics & Gynaecology” This review discusses physiological skin changes and specific dermatoses in pregnancy but reports no new clinical results, emphasizing careful diagnosis and management due to potential fetal risks in rare cases.
4 citations
,
December 2024 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” In this retrospective cohort study, researchers found that Taiwanese mothers with atopic dermatitis had a higher risk of various pregnancy complications and that their children were more likely to develop certain conditions like AD, asthma, and ADHD, compared to non-AD mothers and their children.
1 citations
,
January 2015 in “Case reports in endocrinology” This case report highlights that women with nonclassical congenital adrenal hyperplasia should be aware of the risk of having a child with classical CAH if their partner also carries a severe mutation.
September 2025 in “Archives of Medicine and Health Sciences” In this study, a high prevalence of anemia and iron deficiency was reported among first-trimester pregnant women in Mysore, with sociodemographic factors like residence, education, and BMI significantly influencing anemia risk.
October 2024 in “Andrology” This study investigated paternal drug exposure using FDA data and identified significant associations with reproductive health risks, including congenital anomalies linked to immunosuppressive drugs, and emphasized specific risk combinations like biologics and abortion, diazepam and small for date baby, and finasteride and cryptorchidism.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that anemic pregnant women in Casablanca-Settat and Marrakech-Safi regions had more exposure to risk factors like younger age and coffee consumption, while antenatal care reduced anemia risk.
1 citations
,
June 2019 in “Journal of Biological and Scientific Opinion” This article highlights the health risks associated with adding paraphenylenediamine to mehndi, such as contact dermatitis and asthma, and emphasizes the need for regulatory checks as its use grows among cancer patients, women with alopecia, and pregnant individuals.
73 citations
,
March 2014 in “Journal of The American Academy of Dermatology” Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.
41 citations
,
February 2012 in “Journal of Neuroendocrinology” This study suggests that in late pregnancy, allopregnanolone induces opioid inhibition of oxytocin secretion in response to immune challenge, potentially minimizing the risk of preterm labor in rats.